Next Article in Journal
The activity of the Clinic of Ophthalmology as the subunit of the Faculty of Medicine of the University of Lithuania (Vytautas Magnus University) during 1922–1938
Previous Article in Journal
The need of the elderly for nursing and social services in the community of Kaunas district
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Open AccessArticle

Ischemic cardiomyopathy: possibilities of surgical treatment

Department of Cardiosurgery
Department of Cardiology
Institute of Cardiology, Kaunas University of Medicine, Lithuania
Author to whom correspondence should be addressed.
Medicina 2007, 43(11), 909;
Received: 5 June 2007 / Accepted: 29 October 2007 / Published: 3 November 2007
The high morbidity and mortality in patients with serious heart failure is a therapeutic challenge for current medicine. The leading cause of left ventricular dysfunction remains ischemic heart disease. Coronary artery bypass surgery is a treatment of choice in moderate-to-severe ischemic cardiomyopathy. The scarcity of completed prospective randomized clinical trials and high surgical risks create significant uncertainty concerning the optimal current treatment strategy. The role of imaging techniques of assessment for myocardial viability based on current guidelines may be very important in clinical decision-making. Present paper reviews some of the relevant literature concerning surgical treatment of ischemic cardiomyopathy and current evidence-based recommendations on this method of treatment. In advanced heart failure, coronary revascularization alone is an insufficient treatment modality. In the presence of moderate-to-severe ischemic mitral regurgitation, mitral valve repair or replacement should be considered at coronary artery bypass grafting surgery. One of the most common mechanisms of ischemic mitral regurgitation is Carpentier’s type IIIb dysfunction, in which an undersized mitral anuloplasty might be helpful. Surgery of left ventricular shape and volume restoration leads to improvement of left ventricular function in patients with ischemic cardiomyopathy. When the results from three ongoing prospective randomized studies – the Surgical Treatment for Ischemic Heart Disease trial, Heart Failure Revascularization trial, the PET and Recovery Following Revascularization-2 trial – determining outcome of revascularization versus medical therapy are available, clinicians will have reliable data for making decisions concerning the optimum treatment strategy. At present, the choice of management still remains based on the data obtained from available retrospective trials or the state of art in the field.
Keywords: ischemic cardiomyopathy; heart failure; ischemic mitral regurgitation; left ventricular remo- deling; revascularization ischemic cardiomyopathy; heart failure; ischemic mitral regurgitation; left ventricular remo- deling; revascularization
MDPI and ACS Style

Benetis, R.; Šimukauskienė, A.; Jankauskienė, L.; Kavoliūnienė, A. Ischemic cardiomyopathy: possibilities of surgical treatment. Medicina 2007, 43, 909.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop